Isoprenoids, small GTPases and Alzheimer's disease.

[1]  U. Igbavboa,et al.  Statins and neuroprotection , 2010, Annals of the New York Academy of Sciences.

[2]  W. Markesbery,et al.  NOX activity is increased in mild cognitive impairment. , 2010, Antioxidants & redox signaling.

[3]  W. G. Wood,et al.  Modulation of Cholesterol, Farnesylpyrophosphate, and Geranylgeranylpyrophosphate in Neuroblastoma SH-SY5Y-APP695 Cells: Impact on Amyloid Beta-Protein Production , 2010, Molecular Neurobiology.

[4]  R. Hohl,et al.  Differential activities of thalidomide and isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells. , 2010, Leukemia research.

[5]  Binyan Lu,et al.  Forgetting Is Regulated through Rac Activity in Drosophila , 2010, Cell.

[6]  D. Butterfield,et al.  Role of oxidative stress in the progression of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[7]  Huaiping Zhu,et al.  Rabex-5 is a Rab22 effector and mediates a Rab22-Rab5 signaling cascade in endocytosis. , 2009, Molecular biology of the cell.

[8]  Y. Terayama,et al.  Increase in the Oxidized/Total Coenzyme Q-10 Ratio in the Cerebrospinal Fluid of Alzheimer’s Disease Patients , 2009, Dementia and Geriatric Cognitive Disorders.

[9]  D. Volmer,et al.  Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients , 2009, Neurobiology of Disease.

[10]  Barbara Karten,et al.  Mechanisms and consequences of impaired lipid trafficking in Niemann-Pick type C1-deficient mammalian cells. , 2009, Biochimica et biophysica acta.

[11]  T. Kihara,et al.  Rac1 inhibition negatively regulates transcriptional activity of the amyloid precursor protein gene , 2009, Journal of neuroscience research.

[12]  C. D’Souza-Schorey,et al.  Neurodegeneration in Niemann-Pick Type C disease and Huntington's disease: impact of defects in membrane trafficking. , 2009, Current drug targets.

[13]  M. L. Genova,et al.  Mobility and function of coenzyme Q (ubiquinone) in the mitochondrial respiratory chain. , 2009, Biochimica et biophysica acta.

[14]  D. Kögel,et al.  The interaction of beta-amyloid protein with cellular membranes stimulates its own production. , 2009, Biochimica et biophysica acta.

[15]  Thomas Arendt,et al.  Synaptic degeneration in Alzheimer’s disease , 2009, Acta Neuropathologica.

[16]  A. A. Farooqui,et al.  Aging: An important factor for the pathogenesis of neurodegenerative diseases , 2009, Mechanisms of Ageing and Development.

[17]  R. Sato.  SREBPs: protein interaction and SREBPs , 2009, The FEBS journal.

[18]  R. Goody,et al.  Biophysical Analysis of the Interaction of Rab6a GTPase with Its Effector Domains* , 2009, Journal of Biological Chemistry.

[19]  R. Rodenburg,et al.  Mitochondrial complex I deficiency: from organelle dysfunction to clinical disease. , 2008, Brain : a journal of neurology.

[20]  Jun Tan,et al.  Normal brain aging clinical, immunological, neuropsychological, and neuroimaging features. , 2009, International review of neurobiology.

[21]  J. Mallet,et al.  Neurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase , 2008, The Journal of Neuroscience.

[22]  B. Liang,et al.  TrkB-mediated activation of geranylgeranyltransferase I promotes dendritic morphogenesis , 2008, Proceedings of the National Academy of Sciences.

[23]  Y. Hirooka.  Role of reactive oxygen species in brainstem in neural mechanisms of hypertension , 2008, Autonomic Neuroscience.

[24]  F. Collins,et al.  A farnesyltransferase inhibitor prevents both the onset and late progression of cardiovascular disease in a progeria mouse model , 2008, Proceedings of the National Academy of Sciences.

[25]  T. Prolla,et al.  Evolution of the Aging Brain Transcriptome and Synaptic Regulation , 2008, PloS one.

[26]  A. Iwamatsu,et al.  The GDP-dependent Rab27a effector coronin 3 controls endocytosis of secretory membrane in insulin-secreting cell lines , 2008, Journal of Cell Science.

[27]  D. Russell,et al.  Biphasic requirement for geranylgeraniol in hippocampal long-term potentiation , 2008, Proceedings of the National Academy of Sciences.

[28]  D. Volmer,et al.  Isoprenoid quantitation in human brain tissue: a validated HPLC–fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP) , 2008, Analytical and bioanalytical chemistry.

[29]  R. Hohl,et al.  Quantitative determination of farnesyl and geranylgeranyl diphosphate levels in mammalian tissue. , 2008, Analytical biochemistry.

[30]  T. Suuronen,et al.  ROCK, PAK, and Toll of synapses in Alzheimer's disease. , 2008, Biochemical and biophysical research communications.

[31]  R. DeBose-Boyd.  Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase , 2008, Cell Research.

[32]  A. Harris,et al.  Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer , 2008, British Journal of Cancer.

[33]  G. Cole,et al.  p21-activated Kinase-aberrant Activation and Translocation in Alzheimer Disease Pathogenesis* , 2008, Journal of Biological Chemistry.

[34]  F. Porter.  Smith–Lemli–Opitz syndrome: pathogenesis, diagnosis and management , 2008, European Journal of Human Genetics.

[35]  E. Castrén,et al.  Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro. , 2008, Molecular biology of the cell.

[36]  S. Paul,et al.  Geranylgeranyl pyrophosphate stimulates γ‐secretase to increase the generation of Aβ and APP‐CTFγ , 2008 .

[37]  S. Paul,et al.  Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma. , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  D. Linseman,et al.  Diverse roles of Rho family GTPases in neuronal development, survival, and death. , 2008, Frontiers in bioscience : a journal and virtual library.

[39]  D. Small,et al.  The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. , 2008, Brain : a journal of neurology.

[40]  N. Watts,et al.  Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy , 2008, Osteoporosis International.

[41]  Geng Li,et al.  Coenzyme Q10 Attenuates β-Amyloid Pathology in the Aged Transgenic Mice with Alzheimer Presenilin 1 Mutation , 2008, Journal of Molecular Neuroscience.

[42]  Peter J Espenshade,et al.  Regulation of sterol synthesis in eukaryotes. , 2007, Annual review of genetics.

[43]  T. Neumann-Haefelin,et al.  NADPH Oxidase Plays a Central Role in Blood-Brain Barrier Damage in Experimental Stroke , 2007, Stroke.

[44]  F. Baas,et al.  Rab6 is increased in Alzheimer's disease brain and correlates with endoplasmic reticulum stress , 2007, Neuropathology and applied neurobiology.

[45]  W. K. Schmidt,et al.  Small-Molecule Inhibitors of the Rce1p CaaX Protease , 2007, Journal of biomolecular screening.

[46]  G. Landreth,et al.  Statins Reduce Amyloid-β Production through Inhibition of Protein Isoprenylation* , 2007, Journal of Biological Chemistry.

[47]  Gunter P. Eckert,et al.  Cholesterol-lowering drugs and Alzheimer's disease , 2007 .

[48]  Michalis V. Karamouzis,et al.  Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets , 2007, Nature Reviews Drug Discovery.

[49]  E. Klann,et al.  Translocation and activation of Rac in the hippocampus during associative contextual fear learning , 2007, Neurobiology of Learning and Memory.

[50]  K. Sunagawa,et al.  Inhibition of Rac1-Derived Reactive Oxygen Species in Nucleus Tractus Solitarius Decreases Blood Pressure and Heart Rate in Stroke-Prone Spontaneously Hypertensive Rats , 2007, Hypertension.

[51]  T. Shirao,et al.  Role of actin cytoskeleton in dendritic spine morphogenesis , 2007, Neurochemistry International.

[52]  I. Buhăescu,et al.  Mevalonate pathway: a review of clinical and therapeutical implications. , 2007, Clinical biochemistry.

[53]  T. M. Dore,et al.  Inhibition of the CaaX proteases Rce1p and Ste24p by peptidyl (acyloxy)methyl ketones. , 2007, Biochimica et biophysica acta.

[54]  C. Dotti,et al.  Transmitting on actin: synaptic control of dendritic architecture , 2007, Journal of Cell Science.

[55]  R. Baron,et al.  Rab GTPases Containing a CAAX Motif Are Processed Post-geranylgeranylation by Proteolysis and Methylation* , 2007, Journal of Biological Chemistry.

[56]  M. Alegret,et al.  Pleiotropic effects of statins and related pharmacological experimental approaches. , 2006, Timely topics in medicine. Cardiovascular diseases.

[57]  A. Lajtha,et al.  Neural membranes and transport , 2007 .

[58]  A. Majid,et al.  The therapeutic potential of statins in neurological disorders. , 2007, Current medicinal chemistry.

[59]  G. Landreth,et al.  Statins reduce amyloid-beta production through inhibition of protein isoprenylation. , 2007, The Journal of biological chemistry.

[60]  M. Schiller.  Coupling receptor tyrosine kinases to Rho GTPases--GEFs what's the link. , 2006, Cellular signalling.

[61]  Herbert Waldmann,et al.  Therapeutic intervention based on protein prenylation and associated modifications , 2006, Nature chemical biology.

[62]  Udo Oppermann,et al.  The Crystal Structure of Human Geranylgeranyl Pyrophosphate Synthase Reveals a Novel Hexameric Arrangement and Inhibitory Product Binding* , 2006, Journal of Biological Chemistry.

[63]  W. Mobley,et al.  TrkB binds and tyrosine-phosphorylates Tiam1, leading to activation of Rac1 and induction of changes in cellular morphology , 2006, Proceedings of the National Academy of Sciences.

[64]  E. Klann,et al.  NMDA receptor activation induces translocation and activation of Rac in mouse hippocampal area CA1. , 2006, Biochemical and biophysical research communications.

[65]  R. Vassar,et al.  Isoprenoids and Alzheimer's disease: A complex relationship , 2006, Neurobiology of Disease.

[66]  M. Philips,et al.  Thematic review series: Lipid Posttranslational Modifications CAAX modification and membrane targeting of Ras Published, JLR Papers in Press, March 16, 2006. , 2006, Journal of Lipid Research.

[67]  J. Schellens,et al.  Absolute quantification of farnesylated Ras levels in complex samples using liquid chromatography fractionation combined with tryptic digestion and electrospray tandem mass spectrometry. , 2006, Analytical biochemistry.

[68]  M. Mattson,et al.  Ageing and neuronal vulnerability , 2006, Nature Reviews Neuroscience.

[69]  R. Baron,et al.  Thematic review series: Lipid Posttranslational Modifications. Geranylgeranylation of Rab GTPases Published, JLR Papers in Press, January 9, 2006. , 2006, Journal of Lipid Research.

[70]  M. Goldstein,et al.  Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin , 2006, The Journal of experimental medicine.

[71]  R. Hohl,et al.  Anti-cancer therapy: targeting the mevalonate pathway. , 2006, Current cancer drug targets.

[72]  Agnès Gruart,et al.  Involvement of the CA3–CA1 Synapse in the Acquisition of Associative Learning in Behaving Mice , 2006, The Journal of Neuroscience.

[73]  S. Weggen,et al.  Inhibitors of Rho‐kinase modulate amyloid‐β (Aβ) secretion but lack selectivity for Aβ42 , 2006 .

[74]  S. Weggen,et al.  Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42. , 2006, Journal of neurochemistry.

[75]  F. Fumagalli,et al.  The expanding role of BDNF: a therapeutic target for Alzheimer's disease? , 2006, The Pharmacogenomics Journal.

[76]  S. Murthy,et al.  Regulation of Fatty Acid Synthesis by Farnesyl Pyrophosphate* , 2005, Journal of Biological Chemistry.

[77]  A. Hall,et al.  Rho GTPases and the control of cell behaviour. , 2005, Biochemical Society transactions.

[78]  J. Olson,et al.  Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease , 2005, The Journal of Neuroscience.

[79]  J. Koenigsknecht-Talboo,et al.  Mechanisms of Statin-mediated Inhibition of Small G-protein Function* , 2005, Journal of Biological Chemistry.

[80]  Karen N Conneely,et al.  Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[81]  T. Vollmer,et al.  HMG‐CoA reductase inhibitor augments survival and differentiation of oligodendrocyte progenitors in animal model of multiple sclerosis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[82]  R. Vassar,et al.  Statins Cause Intracellular Accumulation of Amyloid Precursor Protein, β-Secretase-cleaved Fragments, and Amyloid β-Peptide via an Isoprenoid-dependent Mechanism* , 2005, Journal of Biological Chemistry.

[83]  T. Kodama,et al.  Association of active γ-secretase complex with lipid rafts Published, JLR Papers in Press, Feburary 16, 2005. DOI 10.1194/jlr.M400333-JLR200 , 2005, Journal of Lipid Research.

[84]  Gang-yi Wu,et al.  Synaptic localization of a functional NADPH oxidase in the mouse hippocampus , 2005, Molecular and Cellular Neuroscience.

[85]  Pritam Das,et al.  Diverse compounds mimic Alzheimer disease–causing mutations by augmenting Aβ42 production , 2005, Nature Medicine.

[86]  S. Sebti.  Protein farnesylation: implications for normal physiology, malignant transformation, and cancer therapy. , 2005, Cancer cell.

[87]  Mary B. Kennedy,et al.  Spine architecture and synaptic plasticity , 2005, Trends in Neurosciences.

[88]  Krister Wennerberg,et al.  The Ras superfamily at a glance , 2005, Journal of Cell Science.

[89]  J. Crapo,et al.  Activation of NADPH oxidase and extracellular superoxide production in seizure‐induced hippocampal damage , 2005, Journal of neurochemistry.

[90]  G. Prendergast,et al.  Modulation of Statin-Activated Shedding of Alzheimer APP Ectodomain by ROCK , 2005, PLoS medicine.

[91]  E. Bergamini,et al.  Accumulation of dolichol in older tissues satisfies the proposed criteria to be qualified a biomarker of aging. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.

[92]  R. Vassar,et al.  Statins cause intracellular accumulation of amyloid precursor protein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism. , 2005, The Journal of biological chemistry.

[93]  J. Kaye,et al.  Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction. , 2005, Journal of Alzheimer's disease : JAD.

[94]  T. Kodama,et al.  Association of active gamma-secretase complex with lipid rafts. , 2005, Journal of lipid research.

[95]  R. Hohl,et al.  Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cells. , 2005, Analytical biochemistry.

[96]  S. J. McTaggart,et al.  Isoprenylated proteins , 2005, Cellular and Molecular Life Sciences CMLS.

[97]  L. Van Aelst,et al.  The role of the Rho GTPases in neuronal development. , 2005, Genes & development.

[98]  W. G. Wood,et al.  Statins: drugs for Alzheimer’s disease? , 2005, Journal of Neural Transmission.

[99]  T. Arendt.  Neurodegeneration and plasticity , 2004, International Journal of Developmental Neuroscience.

[100]  Channing J Der,et al.  Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? , 2004, Trends in cell biology.

[101]  S. Pfeffer,et al.  Targeting Rab GTPases to distinct membrane compartments , 2004, Nature Reviews Molecular Cell Biology.

[102]  L. Dietrich,et al.  On the mechanism of protein palmitoylation , 2004, EMBO reports.

[103]  J. Dietschy,et al.  Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.R400004-JLR200 , 2004, Journal of Lipid Research.

[104]  A. Memon.  The role of ADP-ribosylation factor and SAR1 in vesicular trafficking in plants. , 2004, Biochimica et biophysica acta.

[105]  J. Settleman,et al.  GAP control: regulating the regulators of small GTPases. , 2004, Trends in cell biology.

[106]  J. Smotrys,et al.  Palmitoylation of intracellular signaling proteins: regulation and function. , 2004, Annual review of biochemistry.

[107]  M. Segal,et al.  Activation of PKC induces rapid morphological plasticity in dendrites of hippocampal neurons via Rac and Rho‐dependent mechanisms , 2004, The European journal of neuroscience.

[108]  R. Hohl,et al.  Isoprenoids: Remarkable diversity of form and function , 2004, Lipids.

[109]  F. Baas,et al.  Rab6 membrane association is dependent of Presenilin 1 and cellular phosphorylation events. , 2004, Brain research. Molecular brain research.

[110]  E. Chiellini,et al.  Ageing and oxidative stress: a role for dolichol in the antioxidant machinery of cell membranes? , 2004, Journal of Alzheimer's disease : JAD.

[111]  V. Pallottini,et al.  Age-related changes of isoprenoid biosynthesis in rat liver and brain , 2004, Biogerontology.

[112]  Joseph L Goldstein,et al.  Insig-dependent Ubiquitination and Degradation of Mammalian 3-Hydroxy-3-methylglutaryl-CoA Reductase Stimulated by Sterols and Geranylgeraniol* , 2003, Journal of Biological Chemistry.

[113]  R. Maccioni,et al.  Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer's disease , 2003, Neuroreport.

[114]  L. Thal,et al.  Idebenone treatment fails to slow cognitive decline in Alzheimer’s disease , 2003, Neurology.

[115]  M. Sheng,et al.  Targeted Protein Degradation and Synapse Remodeling by an Inducible Protein Kinase , 2003, Science.

[116]  Valentina Gelfanova,et al.  Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß42 by Inhibiting Rho , 2003, Science.

[117]  Yixian Zheng,et al.  Ran in the spindle checkpoint: a new function for a versatile GTPase. , 2003, Trends in cell biology.

[118]  R. Muschel,et al.  Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations. , 2003, Cancer research.

[119]  S. Liao,et al.  Transcriptional regulation of farnesyl pyrophosphate synthase by liver X receptors , 2003, Steroids.

[120]  U. Igbavboa,et al.  Cholesterol Trafficking and Amyloid Beta Peptides , 2003, Pharmacopsychiatry.

[121]  H. Waterham,et al.  Isoprenoid biosynthesis in hereditary periodic fever syndromes and inflammation , 2003, Cellular and Molecular Life Sciences CMLS.

[122]  Sebastian Maurer-Stroh,et al.  Protein prenyltransferases , 2003, Genome Biology.

[123]  U. Igbavboa,et al.  Amyloid beta-protein interactions with membranes and cholesterol: causes or casualties of Alzheimer's disease. , 2003, Biochimica et biophysica acta.

[124]  Karsten Weis,et al.  Regulating Access to the Genome Nucleocytoplasmic Transport throughout the Cell Cycle , 2003, Cell.

[125]  F. Liu,et al.  Nonsteroidal anti-inflammatory drugs can lower amyloidogenic Abeta42 by inhibiting Rho. , 2003, Science.

[126]  J. Downward.  Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[127]  K. Yanagisawa.  Cholesterol and pathological processes in Alzheimer's disease , 2002, Journal of neuroscience research.

[128]  D. Selkoe.  Alzheimer's Disease Is a Synaptic Failure , 2002, Science.

[129]  J. Gustafsson,et al.  Liver X receptors in the central nervous system: From lipid homeostasis to neuronal degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[130]  H. You,et al.  Implication of the small GTPase Rac1 in the generation of reactive oxygen species in response to beta-amyloid in C6 astroglioma cells. , 2002, The Biochemical journal.

[131]  A. Hall,et al.  Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. , 2002, Genes & development.

[132]  Ger J. A. Ramakers,et al.  Rho proteins, mental retardation and the cellular basis of cognition , 2002, Trends in Neurosciences.

[133]  L. Van Aelst,et al.  The role of Rho GTPases in disease development. , 2002, Gene.

[134]  A. Ridley,et al.  Rho family proteins: coordinating cell responses. , 2001, Trends in cell biology.

[135]  H. Shimano.  Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. , 2001, Progress in lipid research.

[136]  P. Faust,et al.  Purification of brain peroxisomes and localization of 3-hydroxy-3-methylglutaryl coenzyme A reductase. , 2001, European journal of biochemistry.

[137]  L. T. McGrath,et al.  Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. , 2001, QJM : monthly journal of the Association of Physicians.

[138]  J. Pereira-Leal,et al.  Prenylation of Rab GTPases: molecular mechanisms and involvement in genetic disease , 2001, FEBS letters.

[139]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[140]  C. Bergmann,et al.  Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[141]  Marino Zerial,et al.  Rab proteins as membrane organizers , 2001, Nature Reviews Molecular Cell Biology.

[142]  M. Hennerici,et al.  Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[143]  E. Kojro,et al.  Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[144]  L. Luo.  RHO GTPASES in neuronal morphogenesis , 2000, Nature Reviews Neuroscience.

[145]  G. Siegel,et al.  Neurotrophic factors in Alzheimer’s and Parkinson’s disease brain , 2000, Brain Research Reviews.

[146]  A. Munnich,et al.  Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency , 2000, The Lancet.

[147]  A. Hall,et al.  Rho GTPases and their effector proteins. , 2000, The Biochemical journal.

[148]  A. Munnich,et al.  A mutation in the human heme A:farnesyltransferase gene (COX10 ) causes cytochrome c oxidase deficiency. , 2000, Human molecular genetics.

[149]  Jaesun Chun,et al.  Akt Protein Kinase Inhibits Rac1-GTP Binding through Phosphorylation at Serine 71 of Rac1* , 2000, The Journal of Biological Chemistry.

[150]  B. Olofsson,et al.  Rho guanine dissociation inhibitors: pivotal molecules in cellular signalling. , 1999, Cellular signalling.

[151]  D. Campion,et al.  Presenilins interact with Rab11, a small GTPase involved in the regulation of vesicular transport. , 1999, Human molecular genetics.

[152]  D J Stephens,et al.  The role of cholesterol in the biosynthesis of beta-amyloid. , 1999, Neuroreport.

[153]  T. Taniguchi,et al.  Differential involvement of small G proteins in Alzheimer's disease. , 1999, International journal of molecular medicine.

[154]  W. Markesbery,et al.  Oxidative Alterations in Alzheimer's Disease , 1999, Brain pathology.

[155]  Sangram S. Sisodia,et al.  Dual Roles for Ste24p in Yeast a-Factor Maturation: NH2-terminal Proteolysis and COOH-terminal CAAX Processing , 1998, The Journal of cell biology.

[156]  S. Michaelis,et al.  Mammalian Prenylcysteine Carboxyl Methyltransferase Is in the Endoplasmic Reticulum* , 1998, The Journal of Biological Chemistry.

[157]  S. DeKosky,et al.  Structural correlates of cognition in dementia: quantification and assessment of synapse change. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[158]  M. Andersson,et al.  Age-dependent modifications in the metabolism of mevalonate pathway lipids in rat brain , 1995, Mechanisms of Ageing and Development.

[159]  T. Chojnacki,et al.  Distribution of Branch Point Prenyltransferases in Regions of Bovine Brain , 1995, Journal of neurochemistry.

[160]  G. Dallner,et al.  Biochemical, physiological and medical aspects of ubiquinone function. , 1995, Biochimica et biophysica acta.

[161]  H. Sagami,et al.  Purification and properties of geranylgeranyl-diphosphate synthase from bovine brain. , 1994, The Journal of biological chemistry.

[162]  K. Kristensson,et al.  Isoprenoids in aging and neurodegeneration , 1994, Neurochemistry International.

[163]  J. Ericsson,et al.  Distribution of prenyltransferases in rat tissues. Evidence for a cytosolic all-trans-geranylgeranyl diphosphate synthase. , 1993, The Journal of biological chemistry.

[164]  J. Ericsson,et al.  Distribution of Prenyltransferases in Rat Tissues , 1993 .

[165]  K. Kristensson,et al.  Lipid Composition in Different Regions of the Brain in Alzheimer's Disease/Senile Dementia of Alzheimer's Type , 1992, Journal of neurochemistry.

[166]  K. Carroll,et al.  Dolichol: function, metabolism, and accumulation in human tissues. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[167]  K. Kristensson,et al.  Ubiquinone, dolichol, and cholesterol metabolism in aging and Alzheimer's disease. , 1992, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[168]  R. Lutz,et al.  Feedback inhibition of polyisoprenyl pyrophosphate synthesis from mevalonate in vitro. Implications for protein prenylation. , 1992, The Journal of biological chemistry.

[169]  H. Brody,et al.  The aging brain , 1992, Acta neurologica Scandinavica. Supplementum.

[170]  K. Kaibuchi,et al.  Small GTP-binding proteins. , 1992, International review of cytology.

[171]  Steven A. Johnson,et al.  BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease , 1991, Neuron.

[172]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[173]  S. Leoni,et al.  Variations of hepatic dolichols during rat development. , 1990, Biochimica et biophysica acta.

[174]  K. Kristensson,et al.  Lipid Compositions of Different Regions of the Human Brain During Aging , 1990, Journal of neurochemistry.

[175]  J. Goldstein,et al.  Regulation of the mevalonate pathway , 1990, Nature.

[176]  T. Chojnacki,et al.  Nonaprenyl-4-hydroxybenzoate transferase, an enzyme involved in ubiquinone biosynthesis, in the endoplasmic reticulum-Golgi system of rat liver. , 1990, The Journal of biological chemistry.

[177]  F. Schroeder,et al.  Membrane properties of dolichol in different age groups of mice. , 1989, Chemistry and physics of lipids.

[178]  T. Chojnacki,et al.  The biological role of dolichol. , 1988, The Biochemical journal.

[179]  K. Kristensson,et al.  Age-dependent changes in the levels of dolichol and dolichyl phosphates in human brain. , 1987, Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry.

[180]  D. Koshland,et al.  Methyl-esterified proteins in a mammalian cell line. , 1985, Biochemistry.

[181]  J. Palo,et al.  Dolichols are elevated in brain tissue from Alzheimer's disease, but not in urinary sediment from Alzheimer's disease and Down's syndrome. , 1985, Neurochemical pathology.

[182]  W. Drost-Hansen,et al.  Interaction of dolichol and dolichyl phosphate with phospholipid bilayers. , 1984, Biochimica et biophysica acta.

[183]  J. Palo,et al.  High Levels of Brain Dolichols in Neuronal Ceroid‐Lipofuscinosis and Senescence , 1983, Journal of neurochemistry.

[184]  R. Pullarkat,et al.  Accumulation of dolichols in brains of elderly. , 1982, The Journal of biological chemistry.

[185]  M. Brown,et al.  Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. , 1980, Journal of lipid research.